AXT Inc (AXTI)’s liquidity ratios and what they mean

The price of AXT Inc (NASDAQ: AXTI) closed at $3.21 in the last session, down -6.41% from day before closing price of $3.43. On the day, 1188006 shares were traded.

Ratios:

We take a closer look at AXTI’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.03 and its Current Ratio is at 2.09. In the meantime, Its Debt-to-Equity ratio is 0.27 whereas as Long-Term Debt/Eq ratio is at 0.01.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Craig Hallum on February 23, 2024, Upgraded its rating to Buy and sets its target price to $3.75 from $2.25 previously.

On February 23, 2024, B. Riley Securities Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $2.40 to $3.80.

Craig Hallum Downgraded its Buy to Hold on February 17, 2023, whereas the target price for the stock was revised from $7 to $5.50.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 1.85 while its Price-to-Book (P/B) ratio in mrq is 0.71.

Stock Price History:

Over the past 52 weeks, AXTI has reached a high of $5.64, while it has fallen to a 52-week low of $1.89.

Shares Statistics:

A total of 44.24M shares are outstanding, with a floating share count of 40.66M. Insiders hold about 6.83% of the company’s shares, while institutions hold 50.77% stake in the company.

Earnings Estimates

The company has ATI Inc. analysts who recommend its stock at the moment. The consensus estimate for the next quarter is $3.21, with high estimates of $0.12 and low estimates of $0.13.

Analysts are recommending an EPS of between $Healthcare and $Technology for the fiscal current year, implying an average EPS of $Technology.

Most Popular

[the_ad id="945"]